Related Experiment Videos
Loss of singing ability caused by vincristine
K Rezvani1, B J Bain, C A Coulter
1Department of Haematology, St Mary's Hospital, London, UK.
Clinical and Laboratory Haematology
|July 29, 1998
Abstract:
Two patients who received vincristine therapy for lymphoma suffered marked impairment of ability to sing as a consequence of neurotoxicity. Slow recovery occurred on drug withdrawal.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Macropolycytes: Severe stress time for neutrophils.
Morphologie : bulletin de l'Association des anatomistes·2020
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.
Science (New York, N.Y.)·2017
The Haematologist and the Infective Complications of HIV Infection.
Hematology (Amsterdam, Netherlands)·2016
Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
Clinical and experimental immunology·2016
Cystic fibrosis presenting with haematological abnormalities.
Clinical and laboratory haematology·2006
T-cell-rich B-cell lymphoma of the spleen presenting with severe hypersplenism.
Clinical and laboratory haematology·2006
Spontaneous splenic haematoma in a multiple myeloma patient receiving pegfilgrastim support.
Clinical and laboratory haematology·2006
Characterization of several amino acid transports and glutamine metabolism in MOLT4 human T4 leukemia cells.
Clinical and laboratory haematology·2006
Osteomylelitis and necrosis of the jaw in patients treated with bisphosphonates: a comparative study focused on multiple myeloma.
Clinical and laboratory haematology·2006
Stage acoustics for chamber music ensembles: Architectural and acoustic predictors.
The Journal of the Acoustical Society of America·2026
Expressive coupling and textural dissociation in classical piano performance: evidence from the ASAP dataset.
Frontiers in psychology·2026